Alcohol, nicotine, caffeine, and mental disorders by Crocq, Marc-Antoine
lcohol,nicotine,and caffeine share several com-
mon features.Being palatable for their mild psychotropic
properties,they are the most widely consumed drugs world-
wide.As licit psychoactive drugs,they are used mostly by
“normal”people,in contrast to illicit “hard drugs,”which are
traditionally viewed as the province of the deviant.Known
to mankind for several centuries,alcohol,nicotine,and caf-
feine have become an important part of culture,serving as
a vehicle for social interaction,shaping the urban landscape
with dedicated places—from the Ottoman coffeehouse to
the German Brauhaus and the Parisian café—stimulating
the opening of international trade routes and bringing sub-
stantial tax revenues to governments.Abnormal patterns of
substance use have been described since antiquity.Aristotle
recorded the effects of alcohol withdrawal and warned that
drinking could be injurious during pregnancy
1;the Roman
physician Celsus held that dependence on intoxicating drink
was a disease.
2Today,alcohol and nicotine are public health
problems because of their association with physical ailments
such as cirrhosis,cancer,and cardiovascular disease.Of these
three substances,only alcohol causes clear neuropsychiatric
sequelae.Frequent heavy drinking,especially when associ-
ated with malnutrition,has been shown to lead to central
nervous system (CNS) deterioration.The Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV),
3 the current nomenclature of the American
Psychiatric Association,has specific diagnostic categories
for alcohol-, nicotine-, and caffeine-related disorders.
According to DSM-IV’s definition,all three substances can
induce dependence.Conversely,patients presenting with
various mental disorders may be more prone than the gen-
eral population to use or abuse these three common sub-
stances.Thus, patients with bipolar depression are more
likely to abuse alcohol at certain times in the course of their
illness.Patients with schizophrenia have high rates of con-
sumption of all three substances,which they use to relieve
dysphoria.
4
Clinical research
175
Alcohol, nicotine, caffeine,
and mental disorders
Marc-Antoine Crocq, MD
Keywords: alcohol; nicotine; caffeine; depression; dependence; withdrawal
Author affiliations: FORENAP, Institute for Research in Neuroscience and
Neuropsychiatry, Rouffach, France
Address for correspondence: Marc-Antoine Crocq, MD, FORENAP, Institute
for Research in Neuroscience and Neuropsychiatry, BP29, 68250 Rouffach,
France 
(e-mail: ma.crocq@ch-rouffach.fr)
A
Alcohol, nicotine, and caffeine are the most widely con-
sumed psychotropic drugs worldwide. They are largely
consumed by normal individuals, but their use is even
more frequent in psychiatric patients. Thus, patients with
schizophrenia tend to abuse all three substances. The
interrelationships between depression and alcohol are
complex. These drugs can all create dependence, as
understood in the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV). Alcohol abuse
is clearly deleterious to the brain, provoking acute and
chronic mental disorders, ranging from intoxication with
impairment of cognition, to delirium tremens, hallucin-
osis, and dementia. In contrast, the main health conse-
quences of nicotine, notably cancer and cardiovascular dis-
eases, lie outside the realm of psychiatry. However, the
issues of nicotine dependence and motivation to smoke
or quit are of concern to psychiatrists.
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The consumption of alcoholic beverages, in the form of
beer or wine,is mentioned in the records of the earliest
known civilizations.Physicians’ prescriptions of beer were
found on Sumerian clay tablets (c 2100 BC).Egyptian doc-
tors in their medical papyri (c 1500 BC) included beer or
wine in about 15% of their prescriptions.
5 Alcohol—an
inebriating substance—is consumed because it relieves the
mind from anxiety and inhibitions. In the 19th century
medical literature,alcohol was recognized as a major cause
of mental morbidity,and the phenomenology of acute and
chronic alcoholism was already well known. Ball,
6 a
renowned professor of psychiatry in Paris,wrote in 1880
that “of all the poisons that,to a variable degree,exert a
deleterious influence on the constitution,alcohol is with-
out doubt the substance whose effects have been most
thoroughly described and meticulously investigated.”
Alcohol and the DSM-IV classification
DSM-IV offers two categories of alcohol use disorders:
alcohol abuse and alcohol dependence.Abuse is a mal-
adaptive pattern of drinking,resulting in adverse conse-
quences (neglect of children or work,marital problems) or
dangerous behavior (driving while drunk).Dependence is
indicated by loss of control and continued drinking despite
alcohol-related problems,and by evidence of tolerance or
symptoms of withdrawal.Typically,the dependent subject
wants to stop drinking but cannot,and morning drinking
is characteristic.The disorders induced by alcohol are well
known,and will not be detailed here.DSM-IV lists with-
drawal delirium (delirium tremens),psychotic disorders
with delusions or hallucinations,persisting dementia,and
persisting amnestic disorder. Recognizing the frequent
association between alcohol and depression,DSM-IV also
includes the category alcohol-induced mood disorder to
diagnose mood disorders developing during,or within a
month,of alcohol intoxication or withdrawal.
Depression and alcohol
The interrelationship between depression and alcohol is
complex,but highly important in clinical practice.About
100 years ago,the readers of a booklet written by Bode,
a German physician,
7 could learn that depression and alco-
hol abuse are often linked.The author thought that regu-
lar drinking could be a consequence of the “depression”
caused by an unfavorable climate,stating for instance that
alcoholism had been observed in Italians moving to the
fog and rain of London, or in German colonial officers
posted in tropical countries.In a more modern vein,Bode
also added that alcohol abuse could be one of the first
symptoms of “melancholia,”the usual term at the time for
today’s major depression.He wrote that the melancholic
patient “turned to the bottle”to alleviate feelings of anxi-
ety,guilt,sorrow,sadness,and mental vacuity.This state-
ment would still be considered pertinent today.Intuitively,
the association between depression and alcohol seems to
have good face value.However,this association is much
more complex than meets the eye. Interestingly, a U-
shaped relationship of depression and alcohol consump-
tion has been observed in large population samples.It was
found that lower-level drinkers had lower depression
scores than both nondrinkers and heavy drinkers.
8The fact
that moderate alcohol users are merrier than teetotalers
is illustrated by Sir John’s comment in Shakespeare’s play,
Henry IV,Part 2 (act 4):“A man cannot make him laugh;
but that’s no marvel;he drinks no wine.”
The causal element in the association between depression
and alcoholism is debatable.Is depression secondary to
alcoholism,or vice versa? Or,are both possible? In the
case of alcohol-induced mood disturbances,alcoholism is
clearly primary,and depression secondary.Mood distur-
bances are characteristic of heavy drinkers,particularly
during withdrawal.When not drinking,alcoholics often
report depression, irritability, suspiciousness, lethargy,
apprehension,anxiety,and poor concentration.About a
quarter of recently detoxified alcoholics have a depres-
sive syndrome.Alcohol-induced depression usually remits
in less than 1 month without specific treatment.The clin-
ical course of depression when it coexists with alcoholism
is generally benign and self-limited, with most patients
becoming euthymic within 2 to 3 weeks of abstention
without antidepressant treatment. In some depressed
alcoholics,however,a more chronic depression persists,
and may predict a worse outcome for the alcoholism.In
that case,antidepressants should definitely be used,since
they may lower the relapse rate.
The reverse of alcohol-induced depression, namely
depression-induced alcoholism, can also be observed.
Drinking may be secondary to depression,when alcohol
is used as self-medication by the patient.The alcoholic
may drink to relieve his mind from sorrow, fear, and
despondency,or to combat loneliness or the blues.Since
alcohol absorption may have a transient arousing or
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efit,but it is doomed in the long run.In fact,as described
in the paragraph above,the paradox is that chronic use of
alcohol is more likely to make the subject more with-
drawn, more depressed, or more anxious. However, it
should be remembered that,although depression can lead
to alcoholism,most cases of alcoholism are not explained
by primary depression,contrary to popular belief.
A primary mood disorder should be particularly sus-
pected in certain circumstances,notably in females and in
the cases of early-onset drinking.Also,the possibility of
bipolar disorder should be kept in mind.
Women may be more at risk than men to develop this
form of secondary alcoholism.The hypothesis that depres-
sive symptoms predicted subsequent alcohol problems for
females,whereas alcohol problems predicted subsequent
depressive symptoms for males,was tested in a random
sample of 1306 adults from Erie County, New York,
assessed in 1986, 1989, and 1993.
9 Measures of alcohol
problems in the previous year included an alcohol
abuse/dependence diagnosis and a heavy alcohol use
index.The Center for Epidemiologic Studies Depression
Scale was used to assess depressive symptoms over 1
month.For females,depressive symptoms predicted sub-
sequent alcohol problems over 3 years (odds ratio 3.04;
95% confidence interval [CI] 1.35-6.80; P<0.01) and 4
years (odds ratio 2.42;95% CI 1.14-5.12;P<0.05),but not
for 7 years.Similarly,another study showed that the risk
of heavy drinking was 2.6 times greater in women with a
history of depressive disorder than in women with no his-
tory of depressive disorder.
10 
Early-onset drinking may often be secondary to a primary
psychiatric disorder.This notion is supported by a study
11
that found that 81% of 339 alcoholics had associated
mental disorders.Alcoholics with onset of heavy drinking
before 20 years of age had significantly more antisocial
personality traits,drug abuse,bipolar disorder,panic dis-
order,suicide attempts,and paternal alcoholism than alco-
holics with onset after age 20 years.Alcoholics with onset
before and after 20 years of age also differed significantly
from each other for cerebrospinal fluid concentrations of
somatostatin.
Bipolar disorder
It is too often ignored that episodic drinking may be a
symptom of bipolar illness.In a recent study,
12 the inde-
pendent familial aggregation of bipolar disorder and alco-
holism,and the finding that the onset of bipolar disorder
tended to precede that of alcoholism, were compatible
with a self-medication hypothesis as the explanation for
the frequent cooccurrence of these disorders;in contrast,
the independent familial aggregation and the tendency
toward an earlier onset of alcoholism than that of non-
bipolar depression suggest that unipolar mood disorders
are frequently secondary to alcoholism.Other authors
13
evaluating the prevalence of substance abuse and depen-
dence among subjects with bipolar I disorder versus bipo-
lar II disorder found that alcohol was the most commonly
abused drug among both bipolar I and bipolar II subjects;
bipolar I subjects appear to have higher rates of substance
abuse and dependence than bipolar II subjects.
Genetics of alcoholism
An association between alcohol and depression can be
inferred from the findings of numerous familial, epi-
demiological,and molecular genetics studies.Adoption
and twin studies had concluded,a few decades ago,that
genetics exerts a small but definite effect on the develop-
ment of alcoholism.
14An important caveat is the difficulty
of discerning whether the biological mother’s contribu-
tion is genetic or environmental (eg,drinking during the
critical periods of gestation and nursing).Also,clinical and
epidemiological studies have consistently revealed an
association between alcohol use disorders and both bipo-
lar and nonbipolar mood disorders. However, the evi-
dence regarding the nature of this association is unclear.
Winokur
15 advanced the “depressive spectrum”hypothe-
sis, on the basis of his findings that persons developing
unipolar depression prior to age 40 had more alcoholism
and antisocial personality in their male relatives.
However,subsequent researchers who investigated the
relatives of patients with unipolar or bipolar depression
were unable to replicate a genetic association between
mood disorders and drinking.There is a consensus that
genetic factors play a role in the vulnerability to mood dis-
order,and it is likely that hereditary factors influence the
appearance of alcoholism too.However,both class of dis-
orders are probably influenced by distinct genetic factors.
Data on family studies or genetic studies generally sug-
gest that alcoholism and depression are two independent
illnesses,albeit both quite common.
Individual differences in the pharmacokinetics and phar-
macodynamics of alcohol were known long before the
advent of molecular genetics.Men metabolize a signifi-
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177cant fraction of alcohol in the stomach prior to absorp-
tion,in contrast to women who have less active stomach
enzymes. Alcohol is absorbed into the bloodstream
through the stomach (20%) and intestine (80%). In
women,alcohol absorption through the stomach is higher
premenstrually and during ovulation.
16 Up to 90% of alco-
hol consumed is metabolized in the liver. The rapidly
developing tolerance to some of the effects of alcohol is
partly attributable to enzyme induction in the liver.The
ability to metabolize acetaldehyde,a compound produced
by the catabolic breakdown of alcohol, is impaired in
some Japanese or Chinese individuals,resulting in flush-
ing and discomfort after moderate amounts of alcohol.
Molecular genetics made it possible to identify polymor-
phisms in genes that intervene in the pharmacokinetics of
alcohol (eg, the enzymes aldehyde dehydrogenase and
alcohol dehydrogenase).
17 Recent research findings have
shown the genetic association or linkage of alcoholism to
genes that also play a role in other psychiatric disorders
and in the response to drug treatment.Examples include
the association of alcoholism with the γ-aminobutyric acid
receptor GABAA
18 (GABA is the major inhibitory neuro-
transmitter of the CNS);the linkage of suicidality,severe
suicide attempts, and alcoholism to the tryptophan
hydroxylase gene
19 (the rate-limiting enzyme in the syn-
thesis of serotonin [5-hydroxytryptamine,5-HT]);the link-
age of antisocial alcoholism to the autoreceptor 5-HT1B
gene
20;and the linkage of severe and antisocial alcoholism
to the dopamine D2 and D4 receptor genes.
21 
Alcoholism and drug treatment
Alcohol interferes with the central metabolism of the
neurotransmitters—especially indolamines—involved in
the pathophysiology and drug treatment of mood disor-
ders.Several lines of research support an important role
for brain 5-HT pathways in the control of alcohol drink-
ing behavior.It is known that drinking increases the rate
of 5-HT turnover and decreases the platelet uptake of 
5-HT.
22 Serotonergic compounds reduce ethanol self-
administration in conditioned rats.
23 Results are consistent
with activation of 5-HT1A and 5-HT1B receptor subtypes
in mediation of the conditioned or secondary reinforcing
properties of ethanol.The observation that alcohol mod-
ifies neurotransmitter function is part of the rationale for
the psychopharmacological treatment of alcoholism.
It was shown that men and women who are diagnosed with
major depression at the time that they are admitted for
inpatient treatment of alcohol dependence have shorter
times to first drink and alcohol relapse.
24This suggests that
it is of paramount importance to diagnose and treat comor-
bid depression in alcoholic patients who are seen for treat-
ment.Antidepressants have shown efficacy in the treat-
ment of alcoholism with comorbid depression, and
sometimes even in the absence of comorbid depression.In
particular,antidepressants have been helpful in the reduc-
tion of craving and relapse rates during detoxification.
When antidepressant treatment should be started is
debatable.Antidepressant treatment should certainly be
initiated if depression persists after 2 to 4 weeks of alco-
hol withdrawal. However, certain authors recommend
using antidepressant drugs much earlier, in order to
diminish alcohol consumption, craving, and the risk of
relapse.It should be kept in mind that the adverse effects
of the drug may be potentiated by alcohol intake if treat-
ment is started early,when the patient is still drinking or
when detoxification is not complete.Also,the patient’s
medical condition may necessitate lower antidepressant
doses.Particular attention should be paid to anticholin-
ergic and cardiovascular adverse effects.The use of tri-
cyclic compounds may be limited by the occurrence of
hepatic and myocardial abnormalities in alcoholic
patients.Also,the pharmacokinetics of the drug may be
changed in the alcoholic.For instance,imipramine clear-
ance is increased in the alcoholic,its half-life is shortened,
and much lower plasma levels will be observed.
25
The choice of medication is likely to be determined by the
availability of various classes of drugs, which differs
between countries.Serotonergic drugs have been exten-
sively studied in depressive alcoholics and they have
proven effective in maintaining abstinence. They may,
therefore, be a useful adjuvant in the therapy of alco-
holism.Selective serotonin reuptake inhibitors (SSRIs)
seem to have short-term effects in alcohol dependence,
and are probably more effective in men and in the pres-
ence of comorbid depression.
26 Citalopram
27 was shown
to decrease alcohol consumption in nondepressed sub-
jects with alcohol dependence. Fluoxetine
28 at antide-
pressant doses was able to prevent relapses in weaned
alcoholics.Trazodone,
29 a relatively selective inhibitor of
5-HT reuptake, was able at low doses to significantly
decrease craving for alcohol in detoxified alcohol-depen-
dent subjects. Tianeptine,
30 a compound that increases 
5-HT reuptake,was shown to be particularly suitable in
depressed patients after withdrawal from alcohol abuse
or dependence, because of its relative lack of sedative,
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31 an
inhibitor of norepinephrine reuptake, was shown to be
superior to placebo on the reduction of alcohol con-
sumption.Besides antidepressants,some studies investi-
gated the effect of mood-regulating agents.Overall,lit-
tle benefit was found with lithium, whereas valproate
seemed more promising.
Recently,acamprosate has been introduced as a clinical
treatment to reduce relapse in recovering alcoholics in
Europe,while naltrexone has been approved for a simi-
lar use by the US Food and Drug Administration.
Acamprosate exerts agonist-like effects at GABA recep-
tors and antagonist effects at the N-methyl-D-aspartate
(NMDA) receptor;its ability to modulate the expression
of NMDA receptor subunits in specific brain regions may
be of relevance for its anticraving properties.
32 Naltrexone
is hypothesized to reduce ethanol consumption by block-
ing central opioid receptors,which in turn modulate the
positive reinforcing properties of ethanol.
33
Nicotine
Tobacco is native to America,where it may have been cul-
tivated by man as early as 5000 to 3000 BC.
34 Columbus
came into contact with Indians smoking tobacco when he
landed in Cuba,on his very first trip to America.The rest
of the story of how the plant quickly conquered the world
is well known.Like caffeine,nicotine may be regarded as
a stimulant.Nicotine is not directly associated with psy-
chiatric disorders, apart from the observation that psy-
chiatric patients smoke more than the general population.
Nicotine’s toxicity concerns mostly the cardiovascular sys-
tem and cancer. The neurotoxic and neuroprotective
properties of nicotine had not been thoroughly investi-
gated until recently.A study in rats
35 has shown that nico-
tine produces selective degeneration in the medial habe-
nula, a region with a dense concentration of nicotinic
cholinergic receptors.A significant public health concern
is the risk to pregnant women. Prenatal exposure to
tobacco probably inflicts damage to the developing brain,
as suggested by a recent study showing upregulation of
nicotinic cholinergic receptors in the brains of monkeys
exposed to tobacco in gestation and the early neonatal
period.
36 Nicotine has a neuroprotective action in neu-
rodegenerative disorders such as Parkinson’s and
Alzheimer’s diseases.It protects neurons against the neu-
rotoxicity caused by β-amyloid,the major component of
senile plaques.
37
Psychological, sociological, and biological factors 
associated with nicotine use
The onset of smoking typically occurs in the teenage
years.Some American studies found that the median age
of initiation is 16 to 17 years.
38 According to recent
French epidemiological data,the mean age of smoking
onset is as early as 14 years.
39 People choose to smoke
because they appreciate the psychoactive, stimulant
effect of nicotine. Smokers report that smoking helps
them concentrate, reason, and perform—observations
consistent with studies demonstrating that nicotine
improves attention,learning,reaction time,and problem
solving. For example, studies suggest that nicotine
increases the speed of sensory information processing in
smokers.
40 Smokers also report that smoking helps them
relax, particularly in stressful situations, and improves
their mood.They report pleasure and reduced anger,ten-
sion,depression,and stress.One explanation for the use
of nicotine is that smokers rely on these positive rein-
forcements to cope with their environment.This hypoth-
esis is borne out by the fact that individuals with psychi-
atric or psychological problems characterized by negative
affect and difficulty coping are more likely to be smok-
ers than individuals who are more emotionally stable.
41
The psychological and societal factors that influence
experimentation with tobacco will also influence the
propensity to experiment with other substances and,gen-
erally,different patterns of behavior.As expected,there
is an association among the use of various psychoactive
substances in adolescents. For instance, the National
Household Survey conducted by the National Institute
on Drug Abuse in 1985 found that,among 12- to 17-year-
olds, the proportion using alcohol and marijuana was
74.2% and 47.3%,respectively,among current smokers,
as compared with only 23.5% and 5.8%, respectively,
among nonsmokers.Similarly,a recent Canadian study
of 13 549 students showed that adolescents who used
alcohol or cannabis or who smoked cigarettes were also
more likely to use stimulants (amphetamines,diet pills)
for recreational purposes.
42 One important factor in
smoking initiation is the example provided by parents
and peers.Smoking is more frequent among adolescents
whose parents smoke or whose boyfriend or girlfriend
smokes.
43 Societal tolerance,the absence of a clear set of
rules,and the permissive attitude of some parents toward
smoking also bear,without a doubt,some responsibility
for initiation of smoking in the young.
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tors have a role in the progression from smoking experi-
mentation to regular smoking.While many young people
are exposed to the pleasurable effects of nicotine,only a
minority go on to become regular smokers.According to
a recent Sofres poll,
44 approximately 22% of the French
population aged 15 or more continues smoking despite
their knowledge of the actual or potential adverse conse-
quences.Admittedly,possessing the theoretical knowledge
that a substance is dangerous in the long term does not
automatically entail that one feels emotionally,personally,
and directly concerned.Psychological factors have been
described by various authors,including psychoanalysts.
45
They include a difficulty solving intrapsychic conflicts and
resorting to acts,substances,or food to alleviate feelings of
boredom,emptiness,or anxiety that cannot be elaborated
psychologically.Individuals who rely on cigarette smoking
to cope with their environment generally consider it an
efficient strategy because of its rapidity of action (nicotine
reaches the brain within seconds) and availability (pur-
chasing cigarettes requires relatively moderate cost and
effort).The psychological factors that lead to smoking are
often the same factors that lead to the use of other sub-
stances.Thus,cigarette smoking is often associated with the
use of other substances,and the quantity of alcohol and
nicotine consumed tends to follow parallel curves (mod-
erate drinkers tending to be moderate smokers,and heavy
drinkers tending to be heavy smokers).
46 Statistically,ciga-
rette smoking and nicotine dependence are more preva-
lent in persons with a history of child abuse and neglect,in
children whose parents have problems with alcohol and
other drugs,in single teenage mothers and their children,
in children and adolescents in foster care, in school
dropouts,unemployed youths,
47 adolescents who are incar-
cerated and those in vocational schools,
48 and in persons
with a history of incarceration.By high-school graduation,
28% of adolescents smoke cigarettes,but their peers who
have dropped out of high school have rates approaching
70%.
49 In adults, smoking is more frequent among
divorcees and single parents.Vulnerability factors may be
undesirable states from which relief is sought.Resorting or
not to smoking—or to other substances—in order to deal
with life stressors or boredom is largely determined by an
individual’s repertoire of coping mechanisms.Delinquent
behavior and experimentation with liquor,beer,and mar-
ijuana are also associated with teenage smoking.Smoking
is also strongly linked to a variety of lifestyle indicators:it
is associated with alcohol and caffeine consumption.
50
Whether genetic factors explain some of the variation in
cigarette smoking is not yet clear.Twin studies have pro-
duced variable estimates of the heritability of smoking
behavior, ranging from 33% to 84% in American and
Australian samples.
51,52 Interindividual differences have
been shown in nicotine intake per cigarette and cotinine
(the metabolite of nicotine) half-life.
53 CYP2A6,a genet-
ically variable liver enzyme, is largely responsible for
metabolizing nicotine to cotinine.
54 One study found that
subjects carrying one or two inactive CYP2A6 alleles have
impaired nicotine metabolism and are underrepresented
in tobacco-dependent populations.
55 Different frequencies
of the inactive CYP2A6 alleles have been reported in var-
ious populations.
56 However, a recent study, based on a
more exact genotyping method,found no relation between
genetic characteristics of nicotine metabolism and ciga-
rette consumption.
57 Dopamine pathways are thought to
mediate the pleasurable effects of nicotine in the brain.
Studies suggest a relationship between genetic polymor-
phisms of the dopamine D2 receptor gene and the
dopamine transporter gene and smoking,indicating that
these genes may belong to a multifactorial set of risk fac-
tors associated with smoking.
58,59 More studies will be
required before these genetic issues are settled.
Nicotine dependence
“Tobacco dependence”was included for the first time in
the nomenclature of mental disorders with the publication
of the Diagnostic and Statistical Manual of Mental
Disorders,Third Edition (DSM-III) in 1980.
60The diagno-
sis of tobacco dependence or addiction did not exist in
second edition, DSM-II (the previous classification in
1968).
61The definitions of dependence are based on con-
sensus and have been repeatedly modified during the last
decades. Prevalence rates of tobacco dependence are
greatly influenced by the definitions chosen.Thus,DSM-
III criteria were so overinclusive that a study
62 of 1006 mid-
dle-aged,male smokers showed that 90% were tobacco
dependent according to DSM-III.Using Diagnostic and
Statistical Manual of Mental Disorders, Third Edition–
Revised (DSM-III-R)
63 criteria, Stanton studied the 12-
month prevalence rate of dependence of 967 daily ciga-
rette-smoking 18-years-olds and found 19.3% to be depen-
dent.
64 In DSM-IV,
3 this diagnostic category is called
“nicotine”dependence instead of “tobacco”dependence.
A similar historical evolution was observed with ICD,the
World Health Organization’s Classification of Diseases.
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65 contains a category for
tobacco dependence,whereas the previous edition,ICD-
9,
66 devised in the mid-1970s,had no such specific category
and offered only a category for nicotine abuse.
Smoking withdrawal and cessation
Motivation and education are key factors.Clinical prac-
tice shows that smoking cessation can only be successful
when an individual has made up his or her mind,is moti-
vated,and has devised a personal strategy for how and
when to stop.The subjective difficulty and the degree of
discomfort entailed in the process vary markedly among
individuals,from minimal in some to substantial in others.
This is greatly influenced by an individual’s psychological
motivation.As part of the smoking cessation process,the
smoker will have to overcome the discomfort due to
dependence and will also have to reverse established
habits reinforced by sociocultural factors.Individuals have
to give up the immediate and short-lived gratification pro-
vided by cigarettes,and they have to change their lifestyle
and routine.The practice of smoking is in large part a
habit,a learned behavior with elements of conditioning,
which is elicited by many stimuli (colors,smells,tastes,aro-
mas,locations,times of the day such as the cigarette in the
morning or after dinner,persons,familiar surroundings).
Lighting up a cigarette is largely a conditioned ritual that
has to be extinguished.The changes produced by with-
drawal are physiological (eg,decreased heart rate),behav-
ioral,and subjective (increased craving,ie,a strong sub-
jective drive to use the substance,anxiety,irritability,etc).
The prevalence of signs and symptoms at 2 days postces-
sation in individuals who quit smoking without assistance
(self-quitters) is as follows
67:anxiety 49%;craving 37%;
decreased heart rate 61%;depression 31%;difficulty con-
centrating 43%;hunger 53%;irritability 38%;nocturnal
awakening 39%;restlessness 46%.Most symptoms begin
6 to 12 hours following smoking cessation,peak in 1 to 3
days, and last on average 3 to 4 weeks.
68 Craving and
hunger are generally the only remaining symptoms 4
weeks after cessation. The apparent degree of depen-
dence and severity of withdrawal symptoms are not well
correlated with ultimate success in smoking cessation.
Decline in the prevalence of smoking 
A decline in the prevalence of smoking has been wit-
nessed since the 1950s. According to a Sofres poll,
43
exsmokers are more numerous than current smokers in
the French population (27% and 22% of the population,
respectively).During the late 1950s,almost 80% of men in
Western European countries were tobacco smokers.A
prevalence of 42% was reported in the USA in 1965.
Thanks in large part to educational efforts,smoking preva-
lence has declined to approximately 20% to 25% in many
Western countries.A striking feature of the decline in cig-
arette smoking over the last past two decades in these
countries has been the emergence of a marked socioeco-
nomic gradient.In Britain,in 1990,only 16% of profes-
sional men and women were cigarette smokers,while 48%
of men and 36% of women in unskilled manual occupa-
tions continued to smoke.
69 This distinction cannot be
explained by biological differences between the two
groups
70; rather, it seems likely that while many people
across all socioeconomic strata are potential smokers,edu-
cation and prevention efforts can reduce smoking fre-
quency.A similar trend has emerged in the USA,where
smoking has declined very significantly among persons
with substantial formal education.When compared with
figures from 1974,1976,and 1977,cigarette smoking preva-
lence had declined by 1990 to 1991 from 18.8% to 3.3%
among physicians (average annual decline of 1.15 per-
centage points);from 31.7% to 18.3% among registered
nurses (average annual decline of 0.88 percentage points);
and from 37.1% to 27.2% among licensed practical nurses
(average annual decline of 0.62 percentage points).
71
NRT and drug treatment
Even though various treatment programs are available,
most smokers quit by using their own,personally devised
method,and most quit without any pharmacological or
professional assistance.Nonetheless,pharmacotherapy
such as nicotine replacement therapy (NRT) can be used
to assist smokers who find it difficult to quit on their own.
NRT is available in the form of nicotine gum or trans-
dermal patches.NRT facilitates the initial period of ces-
sation by reducing the severity of withdrawal symptoms
such as craving and affective discomfort. Studies have
demonstrated that (i) pharmacological treatment is effi-
cacious—NRT doubles the success rate in some cases at
6 months of follow-up
72;(ii) behavioral treatment is itself
more efficacious than NRT; and (iii) success rates are
almost always higher when NRT and behavioral treat-
ment are combined.
73 In general,adding NRT to a behav-
ioral intervention doubles the cessation rate.However,
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181clinical practice shows that a strong personal commitment
and motivation to quit are the essential preconditions to
successful abstinence and,without these,pharmacologi-
cal aids will not have a significant impact on cessation suc-
cess. NRT should not be considered if motivation, the
mainstay of smoking cessation,is not clearly present.One
important limitation of NRT is that the urge to smoke,or
craving,is not solely determined by nicotine deprivation.
74
As discussed earlier, the urge to use tobacco is also
elicited by many environmental stimuli.
Bupropion,which was originally introduced as an antide-
pressant,tends to double the abstinence rate.For instance,
in a double-blind,placebo-controlled study,
75 the abstinence
rates at 12 months were 15.6% in the placebo group, as
compared with 16.4% in the nicotine-patch group,30.3%
in the sustained-release bupropion group,and 35.5% in the
group given bupropion and the nicotine patch.It has been
hypothesized that bupropion,a weak inhibitor of synaptic
reuptake of dopamine,may maintain stimulation of plea-
sure response areas in the absence of nicotine by enhanc-
ing dopamine activity in the nucleus accumbens.
Caffeine
Tea and coffee are major sources of caffeine.Caffeine is
also found in maté,in small concentrations in cocoa,and
in caffeinated soft drinks.Coffee originates from Ethiopia.
It was in widespread use throughout the Islamic world by
the end of the 15th century.A couple of centuries later,
Europeans started cultivating the plants in their colonies.
The history of tea is considerably older,since it was already
being planted and processed in China around the 3rd cen-
tury AD.It is estimated that an average cup of coffee con-
tains 100 mg caffeine,whereas a cup of tea or a 0.3 L glass
of cola beverage contains about 40% of that amount.
Caffeine use
Approximately 80% of the inhabitants of affluent coun-
tries drink coffee or tea daily. Caffeine is appreciated
because it is a stimulant; it induces alertness, elevates
mood, and facilitates ideation. Subjectively, caffeine
increases feelings of well-being,motivation for work,and
desire to socialize. Blockade of A1 and A2A adenosine
receptors appears to be the most likely mechanism of
action for caffeine in brain.
76
Patients with schizophrenia have high caffeine intakes.
77
In nonhumans,caffeine enhances dopamine function by
blocking the A2a adenosine receptor.Thus,caffeine might
be expected to worsen positive symptoms and improve
negative symptoms.
Caffeine consumption seems to be influenced by genetic
factors, to the same degree as alcohol and nicotine. A
study in 486 monozygotic and 335 dizygotic female twin
pairs showed that the resemblance for total caffeine con-
sumption,heavy caffeine use,caffeine intoxication,caf-
feine tolerance,and caffeine withdrawal was substantially
greater in monozygotic than in dizygotic twins,
78 and the
heritability of caffeine consumption was estimated at 35%
to 77%.
Caffeine dependence 
DSM-IV has diagnostic categories for caffeine intoxica-
tion,and caffeine-induced anxiety and sleep disorder.
3The
existence of caffeine dependence is debated.DSM-IV cri-
teria for substance dependence,as applied to caffeine,are
often met in the general population.For instance,about
one quarter of 21 adolescents who consumed caffeine
daily met these criteria in a study in New England.
79A
study of the generic DSM-IV criteria for dependence in
162 caffeine users found that the “strong desire or unsuc-
cessful attempt to stop use” criterion was endorsed by
56% of interviewees.
80 DSM-IV-TR,
81 the recently pub-
lished text revision of DSM-IV,proposes research crite-
ria for caffeine withdrawal.
Caffeine withdrawal
One of the reasons for proposing caffeine as a model of
dependence-inducing drug is the fact that it induces with-
drawal symptoms,although they are limited.Like nicotine,
caffeine use is reinforced by the taste and smell of coffee,
the hedonic psychoactive effect of mental stimulation,and
the desire to avoid the discomfort of withdrawal. The
severity of withdrawal symptoms increases with the caf-
feine maintenance dose. Even short periods of caffeine
deprivation, equivalent to skipping a regular morning
coffee, can produce deficit in sustained attention.
82
Withdrawal symptoms are rapidly relieved by caffeine
intake.Signs and symptoms of withdrawal,in decreasing
order of frequency,include headache,drowsiness,impaired
concentration, work difficulty, depression, anxiety, irri-
tability, nausea or vomiting, and muscle aches and stiff-
ness.
83The withdrawal syndrome usually shows an onset
18 to 24 h after cessation;its intensity peaks between 20 to
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week.Tolerance to the sleep-disturbing effects of caffeine
has been demonstrated.However,there is little evidence
for upward dose adjustment, possibly because of the
unpleasant effects of higher doses.
Since caffeine is not associated with significant health
hazards or incapacitation,its potential to induce depen-
dence does not pose a serious problem for the individual
or society.
Overlapping addictions
No psychoactive drug has been studied in so many indi-
viduals as have alcohol,nicotine,and caffeine.The experi-
ence that we have with these compounds is tantamount to
an open trial conducted over a couple of millennia in bil-
lions of subjects! This review of mankind’s most consumed
drugs could also have encompassed betel and khat,which
are both widely consumed in Africa and Asia for their
mild stimulant properties.In the near future,we are likely
to gain more experience with cannabis,the use of which is
tending to be decriminalized. Since these drugs are so
much appreciated,it may be assumed that they procure
beneficial and pleasant effects.The benefits obtained in
terms of creativity,anxiety reduction,social disinhibition,
and pleasure have been extensively described in poetry
and literature,rather that in medical treatises.
There exists a tendency for some normally functioning
adults to have multiple addictions.This led many authors
to discuss theories of addictive personality.A study
84 of
overlapping addictions to common substances (alcohol,
caffeine,chocolate,or cigarettes) and activities (exercise,
gambling,Internet use,television,or video games) in col-
lege men and women found moderate to large correla-
tions,both within and between substances and activities.
Several gender differences in addictive tendencies were
also revealed:men scored higher than women on addic-
tion to alcohol, cigarettes, gambling, television, and
Internet use, but women scored higher on caffeine and
chocolate. Animal studies have shown that rewards
obtained from various drugs,as well as food,playing,and
sex, stimulate a midbrain reward circuit, involving
dopamine and structures such as the nucleus accumbens.
The issue of addiction is more complex in humans,who
have the conscious capacity to evaluate,in the prefrontal
cortex,whether pleasurable activities are appropriate and
acted upon,or should be deferred or resisted.This fasci-
nating duality of the human,oscillating between biologi-
cal urges and conscious choice,has always been a funda-
mental question in our history,as exemplified by the fact
that our attitude toward intoxicants and games is dis-
cussed in religious texts. ❏
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Alcohol, nicotina, cafeína y trastornos 
mentales
El alcohol, la nicotina y la cafeína son las sustancias
psicotrópicas utilizadas más ampliamente en todo el
mundo. Ellas son consumidas en gran cantidad por
sujetos normales y su utilización es mucho más fre-
cuente en los pacientes psiquiátricos. De hecho los
pacientes esquizofrénicos tienden a abusar de estas
tres sustancias. Las interrelaciones entre depresión y
alcohol son complejas. Todas estas sustancias pueden
crear dependencia, de la manera en que está definida
en el Manual Diagnóstico y Estadístico de los
Trastornos Mentales, 4
a edición (DSM-IV). El abuso de
alcohol es claramente deletéreo para el cerebro, pro-
vocando trastornos mentales agudos y crónicos, que
van desde la intoxicación con deterioro cognitivo
hasta el delirium tremens, la alucinosis y la demencia.
En cambio, las principales consecuencias para la salud
de la nicotina, especialmente el cáncer y las enfer-
medades cardiovasculares, están fuera del dominio
de la psiquiatría. Sin embargo, el tema de la depen-
dencia de la nicotina y la motivación para fumar o
para dejar de hacerlo le conciernen a los psiquiatras.
Alcool, nicotine, caféine et troubles 
mentaux
Alcool, nicotine et caféine sont les substances psy-
chotropes les plus largement utilisées à travers le
monde. Si elles sont largement consommées par les
individus normaux, leur utilisation est encore plus
fréquente chez les patients psychiatriques. Ainsi, les
schizophrènes ont tendance à abuser de ces trois
substances. Par ailleurs, les relations mutuelles entre
dépression et alcool sont complexes. Ces substances
peuvent être à l’origine d’une dépendance, ainsi
qu’elle est définie dans le Manuel Diagnostique et
Statistique des Troubles Mentaux, 4
e édition (DSM-
IV). L’abus d’alcool est clairement délétère pour le
cerveau, provoquant des troubles mentaux aigus et
chroniques allant de l’intoxication avec déficit de la
cognition, au delirium tremens, à l’hallucinose et à
la démence. En revanche, les principales conséquen-
ces de la nicotine en termes de santé, notamment
cancer et maladies cardio-vasculaires, sont hors du
domaine de la psychiatrie. Il n’en reste pas moins que
le problème de la dépendance à la nicotine et la
motivation pour fumer ou s’arrêter font partie des
préoccupations des psychiatres.Alcohol,nicotine,caffeine,and mental disorders - Crocq  Dialogues in Clinical Neuroscience - Vol 5 . No.2 . 2003
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